莱昂氨酸通过激活阿尔茨海默病小鼠模型中的Nrf-2通路来缓解认知功能障碍和减少氧化压力
Yue Xie1, Yaning Jin2, Shuyue Li3
1Department of Neurology, the Second Medical Center and National Clinical Research Center for Geriatric Disease, Chinese PLA General Hospital, Beijing, 100853, People's Republic of China.
Neuropsychiatric disease and treatment
|June 7, 2023
概括
列奥努林在阿尔茨海默氏症患者中改善了认知功能.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 阿尔茨海默病 (AD) 影响全球5000万人,目前的治疗只能提供症状缓解和有限的疗效.
- 研究新型治疗剂对于开发更有效的阿尔茨海默病干预措施至关重要.
研究的目的:
- 为了确定莱昂林能否缓解阿尔茨海默病的小鼠模型 (APP/PS1小鼠) 的认知功能障碍.
- 阐明莱昂努林在阿尔茨海默病中的潜在治疗作用背后的分子机制.
主要方法:
- 在两个月的时间内,口服莱昂林给雄性APP/PS1小鼠.
- 使用新型物体识别 (NOR) 和莫里斯水迷宫 (MWM) 测试进行认知功能评估.
- 对海马神经元损伤,粉样β (Aβ) 水平,氧化应激标志物和Nrf-2信号通路的分析.
主要成果:
- 莱昂林治疗显著改善了APP/PS1小鼠的认知表现.
- 组织病理学分析显示,海马神经元损伤减少.
- 列奥努林降低了Aβ水平和氧化应激,与Nrf-2通路激活和增加HO-1和NQO-1表达有关.
结论:
- 列昂氨酸显示出对阿尔茨海默病的潜在治疗益处.
- 这些发现表明,莱昂林值得进一步研究,因为它是阿尔茨海默病治疗的有前途的候选药物.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
166
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
166
Alzheimer's Disease: Treatment
224
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
224
Alzheimer's Disease: Overview
536
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
536
Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K


